Jiangsu Hengrui Medicine Co., Ltd.

This study tested whether adding the drug SHR3680 to standard hormone therapy could improve outcomes for men with high-risk prostate cancer before they had surgery to remove the prostate. The trial enrolled 391 participants and aimed to see if the combination could eliminate all …

This study tested a combination of three drugs—SHR-1210, famitinib, and chemotherapy—in people with advanced non-squamous non-small-cell lung cancer that had not been treated before. The goal was to see if the combination was safe and helped control the cancer longer than standar…

This study tested an experimental inhaled medicine called HRG2005 in people with moderate to severe chronic obstructive pulmonary disease (COPD). The goal was to see if it improves lung function compared to an active control. About 200 adults aged 40 and older with a history of C…